Upregulation of a chemokine receptor CCR6 and its ligand CCL20 has also been shown to promote STAT3 pathway activation in advanced CTCL [48]. This evidence concerns the gene STAT3 and primary cutaneous T-cell non-Hodgkin lymphoma.